Germany
Update notification · 13.08.2026
Supply shortage: Amsparity
Affected country: Germany · Reported period: 01.05.2026 – 31.08.2026 · Active ingredient: Adalimumab
CountryGermany
PZN18896468
ENR2675062
Notification typeUpdate notification
Start01.05.2026
Expected end31.08.2026
Last update13.08.2026
ReasonOther
ATCL04AB04
Hospital-relevantNo
Notice context
A supply shortage has been recorded for Amsparity in Germany. The stated reason is “Other”. The notice concerns the active ingredient Adalimumab and is not identified as hospital-relevant.
This information describes the reported supply status and is not medical or pharmaceutical treatment advice. Availability, alternatives and further measures must be assessed for each individual case by the responsible pharmaceutical market participants.
Primary source: PharmNet.Bund / BfArM
Official shortage notice for Germany. Responsibility and update procedures follow the information supplied by the relevant authority.
Check the official notice list →